ReviewDrug delivery and translational research2021

Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.

Lara Milane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.